Streptococcus suis serotype 2 mutants deficient in capsular expression

被引:132
作者
Charland, N
Harel, J
Kobisch, M
Lacasse, S
Gottschalk, M
机构
[1] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada
[2] Ctr Natl Etud Vet & Alimentaires, Unite Mycoplasmol Bacteriol, F-22440 Ploufragan, France
来源
MICROBIOLOGY-SGM | 1998年 / 144卷
关键词
Streptococcus suis; Tn916; capsule; mutant; virulence;
D O I
10.1099/00221287-144-2-325
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Streptococcus suis serotype 2 is responsible for a wide variety of porcine infections. In addition, it is considered a zoonotic agent. Knowledge about the virulence factors for this bacterium is limited but its polysaccharide capsule is thought to be one of the most important. Transposon mutagenesis with the self-conjugative transposon Tn916 was used to obtain acapsular mutants from the virulent S. suis type 2 reference strain S735. Clones were screened by colony-dot ELISA with a monoclonal antibody specific for a type 2 capsular epitope and clones that failed to react with the antibody were characterized. Two mutants, 2A and 79, having one and two Tn916 insertions respectively, were chosen for further characterization. Absence of capsule was confirmed by coagglutination, capillary precipitation and capsular reaction tests and by transmission electron microscopy. Absence of capsular polysaccharides correlated with increased hydrophobicity and phagocytosis by both murine macrophages and porcine monocytes compared to the wild-type strain. Furthermore, both mutants were shown to be avirulent in murine and pig models of infection. Finally, mutant ZA was readily eliminated from circulation in mice compared to the wild-type strain, which persisted more than 48 h in blood. Thus, isogenic mutants defective in capsule production demonstrate the importance of capsular polysaccharides as a virulence factor for S. suis type 2.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 46 条
  • [1] THE ROLE OF BACTERIAL HYDROPHOBICITY IN INFECTION - BACTERIAL ADHESION AND PHAGOCYTIC INGESTION
    ABSOLOM, DR
    [J]. CANADIAN JOURNAL OF MICROBIOLOGY, 1988, 34 (03) : 287 - 298
  • [2] ARENDS JP, 1988, REV INFECT DIS, V10, P131
  • [3] BEAUDOIN M, 1992, FEMS MICROBIOL LETT, V99, P111, DOI 10.1111/j.1574-6968.1992.tb05552.x
  • [4] In vitro phagocytosis and survival of Streptococcus suis capsular type 2 inside murine macrophages
    Brazeau, C
    Gottschalk, M
    Vincelette, S
    MartineauDoize, B
    [J]. MICROBIOLOGY-UK, 1996, 142 : 1231 - 1237
  • [5] CAPARON MG, 1991, METHOD ENZYMOL, V204, P556
  • [7] AGGLUTINATION OF STREPTOCOCCUS-SUIS BY SIALIC ACID-BINDING LECTINS
    CHARLAND, N
    KELLENS, JTC
    CAYA, F
    GOTTSCHALK, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (08) : 2220 - 2221
  • [8] Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2
    Charland, N
    Kobisch, M
    MartineauDoize, B
    Jacques, M
    Gottschalk, M
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1996, 14 (04): : 195 - 203
  • [9] Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2
    Charland, N
    Jacques, M
    Lacouture, S
    Gottschalk, M
    [J]. MICROBIOLOGY-SGM, 1997, 143 : 3607 - 3614
  • [10] CLIFTONHADLEY FA, 1981, THESIS U CAMBRIDGE